SamanTree Medical

SamanTree Medical is a private, commercial-stage medtech company with a novel imaging platform for tissue specimen analysis. Its flagship Histolog Scanner, cleared by the FDA (510(k)) in 2024 and CE-marked, provides surgeons and pathologists with rapid, on-site visualization of tissue morphology in about a minute. The system aims to streamline workflows in surgical and pathology settings by offering a digital, non-destructive alternative to traditional frozen section analysis for certain applications. With headquarters in Belgium, R&D in Switzerland, and a US commercial office, the company is positioned for global market penetration.

Proprietary massively parallel confocal microscopy system for rapid, non-destructive, high-resolution imaging of fresh tissue surfaces, combined with a patented fluorescent contrast agent and digital collaboration software.

SamanTree competes in the intraoperative imaging and rapid pathology market. Direct competitors include other companies developing point-of-care histology solutions (e.g., Invenio Imaging, 3Scan) and established but more complex/lengthy technologies like frozen section analysis. It must differentiate on speed, ease of use, specimen preservation, and digital integration.